Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monoclonal antibodies in cancer therapy: 25 years of progress.

× No keyword cloud information.

54 in total

1. Rabbit monoclonal antibody: potential application in cancer therapy.

Authors: Lifeng Feng; Xian Wang; Hongchuan Jin
Journal: Am J Transl Res Date: 2011-04-23 Impact factor: 4.060

2. Biomaterials: Plastic antibodies.

Authors: Karsten Haupt
Journal: Nat Mater Date: 2010-08 Impact factor: 43.841

Review 3. Have we overestimated the benefit of human(ized) antibodies?

Authors: Daniel R Getts; Meghann T Getts; Derrick P McCarthy; Emily M L Chastain; Stephen D Miller
Journal: MAbs Date: 2010-11-01 Impact factor: 5.857

4. Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.

Authors: Yulia Vugmeyster; Xin Xu; Frank-Peter Theil; Leslie A Khawli; Michael W Leach
Journal: World J Biol Chem Date: 2012-04-26

Review 5. Conscripts of the infinite armada: systemic cancer therapy using nanomaterials.

Authors: David A Scheinberg; Carlos H Villa; Freddy E Escorcia; Michael R McDevitt
Journal: Nat Rev Clin Oncol Date: 2010-03-30 Impact factor: 66.675

Review 6. Monoclonal antibodies in cancer immunotherapy.

Authors: Ilgin Kimiz-Gebologlu; Sultan Gulce-Iz; Cigir Biray-Avci
Journal: Mol Biol Rep Date: 2018-10-11 Impact factor: 2.316

7. Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products.

Authors: Qingqiao Tan; Qingcheng Guo; Chen Fang; Chong Wang; Bohua Li; Hao Wang; Jing Li; Yajun Guo
Journal: MAbs Date: 2012-10-02 Impact factor: 5.857

8. Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30.

Authors: Christian Kellner; Andreas Günther; Andreas Humpe; Roland Repp; Katja Klausz; Stefanie Derer; Thomas Valerius; Matthias Ritgen; Monika Brüggemann; Jan Gj van de Winkel; Paul Whi Parren; Michael Kneba; Martin Gramatzki; Matthias Peipp
Journal: Oncoimmunology Date: 2015-06-05 Impact factor: 8.110

Review 9. Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic review.

Authors: Daniel M Geynisman; Chun-Ru Chien; Fabrice Smieliauskas; Chan Shen; Ya-Chen Tina Shih
Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452

10. A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models.

Authors: Yanlan Yu; Pierre Lee; Yaohuang Ke; Yongke Zhang; Qiu Yu; Jonathan Lee; Mingzhen Li; Jialiang Song; Jungang Chen; Jihong Dai; Fernando Jose Rebelo Do Couto; Zhiqiang An; Weimin Zhu; Guo-Liang Yu
Journal: PLoS One Date: 2010-02-05 Impact factor: 3.240